Comment on the use of the cre/loxP recombinase system for gene therapy vectors

Gene Therapy

Volumn 7, Issue 19, 2000, Pages 1706-

  Scott, S D ^a   Marples, B ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOSENSITIZING AGENT; RECOMBINASE; VIRUS DNA;

CATALYSIS; CYTOMEGALOVIRUS; ENZYME ACTIVITY; EXPRESSION VECTOR; GENE CASSETTE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE SWITCHING; GENE TARGETING; GENE THERAPY; GENETIC RECOMBINATION; HUMAN; LETTER; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RADIATION DOSE; RADIOSENSITIVITY; STOP CODON; TISSUE SPECIFICITY;

CYTOMEGALOVIRUS;

EID: 0033753831     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301305     Document Type: Letter

References (5)

1. Radiation to contol gene expression
2. A radiation-controlled molecular switch for use in gene therapy of cancer
3. Bacteriophage P1 site-specific recombination. I. Recombination between IoxP sites
4. Studies on the properties of P1 site-specific recombination: Evidence for topologically unlinked products following recombination
5. Development of synthetic promoters for radiation-mediated gene therapy